查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2044301

抗焦慮日常必需品市場預測至2034年－按產品類型、成分類型、應用、通路、最終用戶和地區分類的全球分析

Anti-Anxiety Daily Essentials Market Forecasts to 2034 - Global Analysis By Product Type, Ingredient Type, Application, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球抗焦慮日常必需品市場預計到 2026 年將達到 41 億美元，並在預測期內以 15.2% 的複合年成長率成長，到 2034 年達到 128 億美元。

抗焦慮日常必需品是指市面上可購買的、融入日常健康生活方式的產品，它們透過植物來源、營養、感官和技術機制，持續提供抗焦慮支持，舒緩神經系統，增強應對心理壓力的能力。此類產品包括膠囊、酊劑和軟糖形式的鎮靜草藥和適應原補充劑；含有L-茶氨酸、鎂、睡茄和西番蓮的舒緩壓力功能飲料；包括精油混合物、擴香器和滾珠在內的芳香療法產品；綜合放鬆套裝；以及透過經皮神經刺激、雙耳音頻和觸覺呼吸引導技術提供抗焦慮的生理設備。

報告的焦慮症盛行率增加

全球焦慮症盛行率不斷上升（世界衛生組織估計，全球約有十三分之一的人患有焦慮症，且疫情後人群的發病率顯著增加），這為易於獲取的處方箋）預防性焦慮管理產品創造了巨大的潛在消費市場。由於醫療系統在限制輕度至中度焦慮症狀的臨床治療方面能力有限，許多消費者轉向了自我主導的焦慮管理產品。雇主和保險公司也日益意識到焦慮對生產力和缺勤率造成的損失，因此在企業健康計畫中加大了對易於獲取的日常焦慮管理產品的投入。

療效差異和成分間相互作用的安全隱患。

產品療效的差異，以及消費者和醫療保健提供者對植物來源抗焦慮藥物與精神藥物之間潛在相互作用的擔憂，阻礙了產品的推廣應用，並影響了專業人士的推薦。據報道，纈草、卡瓦胡椒和西番蓮等植物成分在高劑量或與藥物抗焦慮藥物聯合使用時存在肝毒性風險，因此需要提供詳盡的安全信息，這也使得日常使用的推廣變得複雜。個體對植物性抗焦慮成分的反應差異，導致療效難以預測，進而造成消費者滿意度及再購率不穩定。

與數位心理健康平台整合

與認知行為療法應用、正念應用和線上治療服務等數位心理健康平台建立策略合作夥伴關係，能夠帶來高轉換率的產品發現和分銷機會。積極尋求焦慮管理解決方案的數位心理健康平台使用者是接收日常抗焦慮必需品推薦的理想消費群體。將數位治療性焦慮管理工具與配對的實體抗焦慮產品訂閱相結合的整合方案，提案全面的焦慮管理解決方案，與單獨購買產品或應用相比，能夠顯著提升用戶參與度和終身價值。

非處方抗焦慮藥物市場的競爭

低劑量抗焦慮藥物在多個主要市場的供應日益充足，加上遠端醫療的普及使得人們能夠更快地獲得複方抗焦慮藥物，這給植物來源和膳食補充劑類抗焦慮藥物帶來了競爭壓力。隨著無需面診即可更便捷地獲得藥物類抗焦慮解決方案，消費者的偏好可能會轉向那些被認為比植物來源或膳食補充劑類產品更有效的處方藥。監管核准非處方銷售先前僅憑處方箋才能購買的抗焦慮藥物，這對替代品構成了直接威脅。

新型冠狀病毒（COVID-19）的影響

疫情導致現代臨床史上焦慮症患者人數激增，永久地提高了焦慮症的盛行率，同時也催生了大規模的消費市場，各階層人群（此前從未接觸過心理健康相關消費品）都開始購買易於獲取的日常焦慮管理產品。疫情期間，原本對健康產品興趣寥寥的消費者開始青睞鎮靜補充劑、芳香療法和放鬆產品等品類，並形成了持續的購買行為，其需求甚至超過了疫情前水平。疫情後，經濟不確定性、地緣政治不穩定和氣候變遷等問題引發的結構性焦慮加劇，促使消費者以前所未有的力度投資於日常抗焦慮必需品。

在預測期內，穿戴式壓力測量設備細分市場預計將佔據最大的市場佔有率。

在預測期內，穿戴式壓力管理設備預計將佔據最大的市場經皮。這是因為能夠進行神經刺激和生物回饋療法的穿戴式設備，透過生理學驗證的機制提供可測量的即時焦慮緩解，從而實現了高價位和強大的消費者參與度。經皮迷迷走神經刺激設備、心率變異性（HRV）生物回饋療法訓練設備和觸覺呼吸控制穿戴式設備等，為循證焦慮干預提供了可信度，使其不再僅僅是可有可無的健康配件，而是成為日常健康必需品。此外，這些設備還透過更換耗材電極和平台訂閱費，實現了持續的收入模式。

預計在預測期內，草藥萃取物細分市場將呈現最高的複合年成長率。

在預測期內，草藥萃取物細分市場預計將呈現最高的成長率。這主要歸功於某些植物性抗焦慮成分（例如睡茄KSM-66、薰衣草油萃取物Silexan和標準化西番蓮萃取物）的臨床證據正在迅速累積。這些成分在隨機對照試驗中已證實具有顯著的抗焦慮效果，從而為基於證據的消費品行銷提供了可能。專注於臨床證據的膳食補充劑品牌透過獲得專有標準化植物萃取物的授權，在高速成長的草藥抗焦慮品類中打造了高級產品差異化優勢。

市佔率最大的地區

在預測期內，北美地區預計將佔據最大的市場佔有率，這主要得益於該地區焦慮症患病率最高、消費者在膳食補充劑方面的支出最高，以及其擁有最完善的天然焦慮管理零售生態系統。美國之所以處於領先地位，是因為其在焦慮健康品牌開發方面投入了大量風險投資，擁有主導的藥房和專業健康零售基礎設施，用於推廣抗焦慮補充劑，並且開展了具有影響力的心理健康宣傳活動，從而提高了消費者對相關產品的認知度和接受度。

複合年成長率最高的地區

在預測期內，亞太地區預計將呈現最高的複合年成長率。這主要歸功於東亞和東南亞市場對焦慮症的認知迅速提升（這些市場歷來在焦慮管理消費品的普及方面較為落後），以及政府對心理健康的投資計劃和當地根深蒂固的傳統植物來源鎮靜劑文化。在韓國，焦慮和倦怠危機頻繁，作為全球消費支出最高的健康消費市場之一，韓國對日常抗焦慮必需品的需求尤其迫切。

免費客製化服務

所有購買此報告的客戶均可享受以下免費自訂選項之一。

  • 企業概況
    • 對其他市場參與企業（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 透過產品系列、地理覆蓋範圍和策略聯盟對標領先企業。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰和機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 成長機會和重點投資領域
  • 工業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球抗焦慮日常必需品市場：依產品類型分類

  • 放鬆補充劑
  • 緩解壓力的飲品
  • 芳香療法產品
  • 放鬆套裝
  • 穿戴式壓力測試設備

第6章：全球抗焦慮日常必需品市場：依成分類型分類

  • 草藥萃取物
  • 適應原
  • 維生素和礦物質
  • CBD化合物成分
  • 胺基酸

第7章：全球抗焦慮日常必需品市場：依應用領域分類

  • 減輕壓力
  • 睡眠支持
  • 情緒穩定
  • 認知放鬆
  • 情緒健康

第8章：全球抗焦慮日常必需品市場：依通路分類

  • 線上平台
  • 藥局
  • 超級市場
  • 專賣店
  • 健康診所

第9章：全球抗焦慮日常必需品市場：依最終用戶分類

  • 成人
  • 青年
  • 老年人
  • 社會成員
  • 學生

第10章：全球抗焦慮日常必需品市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 其他
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲地區

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章：產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟、合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章：公司簡介

  • Nestle SA
  • Abbott Laboratories
  • Danone SA
  • Herbalife Nutrition Ltd.
  • Amway Corporation
  • GSK plc
  • Bayer AG
  • Pfizer Inc.
  • Unilever PLC
  • Procter & Gamble Co.
  • Reckitt Benckiser Group
  • Haleon plc
  • Blackmores Limited
  • Nature's Bounty Co.
  • Now Health Group Inc.
  • Garden of Life
  • Himalaya Wellness Company
Product Code: SMRC36090

According to Stratistics MRC, the Global Anti-Anxiety Daily Essentials Market is accounted for $4.1 billion in 2026 and is expected to reach $12.8 billion by 2034 growing at a CAGR of 15.2% during the forecast period. Anti-anxiety daily essentials refer to consumer-accessible, non-prescription products incorporated into everyday wellness routines to provide ongoing anxiolytic support, nervous system calming, and psychological stress resilience through botanical, nutritional, sensory, and technological mechanisms. This category encompasses calming herbal and adaptogenic supplements in capsule, tincture, and gummy formats, stress relief functional beverages incorporating L-theanine, magnesium, ashwagandha, and passionflower, aromatherapy products including essential oil blends, diffusers, and roller applications, comprehensive relaxation kit bundles, and wearable devices delivering physiologically-targeted anxiety relief through transcutaneous neurostimulation, binaural audio, and haptic breathing guidance technologies.

Market Dynamics:

Driver:

Documented anxiety disorder prevalence escalation

Globally documented escalation in anxiety disorder prevalence, with the WHO estimating that anxiety disorders affect approximately one in thirteen people worldwide, and incidence rates rising substantially across post-pandemic populations, is creating a massive addressable consumer market for daily preventive anxiety management products accessible without prescription. Healthcare system capacity limitations restricting clinical anxiety treatment access for mild-to-moderate anxiety experiences are compelling large consumer populations toward self-directed anxiety management product solutions. Employer and insurer recognition of anxiety's productivity and absenteeism costs are driving corporate wellness program investment in accessible daily anxiety management products.

Restraint:

Variable efficacy and ingredient interaction safety concerns

Consumer and healthcare provider concerns about variable product efficacy and potential interactions between botanical anti-anxiety ingredients and prescription psychotropic medications create adoption barriers and professional recommendation hesitancy. Valerian, kava, and passionflower botanical ingredients with documented hepatotoxicity risks at high doses or in combination with pharmaceutical anxiolytics require careful safety communication that complicates marketing of daily consumption positioning. The wide variance in individual response to anxiolytic botanical interventions creates unpredictable efficacy experiences that generate inconsistent consumer satisfaction and repurchase rates.

Opportunity:

Digital mental health platform integration

Strategic partnership with digital mental health platforms, including cognitive behavioral therapy apps, mindfulness applications, and online therapy services represents a high-conversion product discovery and distribution opportunity. Digital mental health platform users actively seeking anxiety management solutions represent highly qualified consumer audiences for anti-anxiety daily essentials product recommendations. Integrated programs combining digital therapeutic anxiety management tools with companion physical anti-anxiety product subscriptions create holistic anxiety management solution propositions with superior consumer engagement and lifetime value compared to standalone product or app adoption.

Threat:

Over-the-counter anxiolytic medication competition

Expanding over-the-counter availability of low-dose anxiolytic medications in multiple major markets, combined with growing telemedicine access enabling rapid prescription anxiolytic medication access, creates competitive pressure on consumer botanical and nutritional anti-anxiety essentials. As pharmaceutical anxiety management solutions become more accessible without requiring in-person clinical consultation, consumer preference may shift toward prescription-equivalent pharmaceutical interventions perceived as more clinically validated than botanical and nutritional daily essentials. Regulatory approvals enabling OTC sale of previously prescription-only anxiolytic medications represent a direct substitution threat.

Covid-19 Impact:

The pandemic produced the largest recorded global anxiety surge in modern clinical history, permanently elevating anxiety disorder prevalence and creating mass consumer markets for accessible daily anxiety management products across demographics not previously engaged with mental wellness consumer goods. Pandemic-era adoption of calming supplements, aromatherapy, and relaxation product categories by previously non-wellness consumers has created durable purchasing behavior that exceeds pre-pandemic demand. Post-pandemic, structural anxiety elevation from economic uncertainty, geopolitical instability, and climate anxiety is maintaining unprecedented consumer investment in daily anti-anxiety essentials.

The Wearable Stress Devices segment is expected to be the largest during the forecast period

The Wearable Stress Devices segment is expected to account for the largest market share during the forecast period, due to the premium pricing and strong consumer engagement of neurostimulation and biofeedback wearable devices delivering measurable, real-time anxiety relief through physiologically validated mechanisms. Devices including transcutaneous vagal nerve stimulators, HRV biofeedback training devices, and haptic breathing regulation wearables provide evidence-based anxiety intervention credibility that positions them as daily essential health devices rather than discretionary wellness accessories, supporting recurring revenue models through consumable electrode replacement and platform subscription fees.

The Herbal Extracts segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Herbal Extracts segment is predicted to witness the highest growth rate, driven by rapidly expanding clinical evidence for specific botanical anxiolytics, including ashwagandha KSM-66, lavender oil extract Silexan, and passionflower standardized extracts demonstrating statistically significant anxiety reduction in randomized controlled trials that enable evidence-based consumer product marketing. Proprietary standardized botanical extract licensing by supplement brands committed to clinical substantiation is creating premium product differentiation within the high-growth herbal anxiolytic category.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the highest documented anxiety disorder prevalence, the largest consumer supplement spending, and the most developed natural anxiety management retail ecosystem. The United States leads with significant venture investment in anxiety wellness brand development, strong pharmacy and specialty health retail infrastructure for anti-anxiety supplement placement, and influential mental health advocacy driving category awareness and consumer trial.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapidly growing anxiety awareness across East and Southeast Asian markets historically underrepresented in anxiety management consumer product adoption, combined with government mental health investment programs and strong traditional botanical calming remedy cultures. South Korea's documented anxiety and burnout crisis is creating particularly acute demand for daily anti-anxiety essential products in one of the world's highest-spending consumer wellness markets.

Key players in the market

Some of the key players in Anti-Anxiety Daily Essentials Market include Nestle S.A., Abbott Laboratories, Danone S.A., Herbalife Nutrition Ltd., Amway Corporation, GSK plc, Bayer AG, Pfizer Inc., Unilever PLC, Procter & Gamble Co., Reckitt Benckiser Group, Haleon plc, Blackmores Limited, Nature's Bounty Co., Now Health Group Inc., Garden of Life, and Himalaya Wellness Company.

Key Developments:

In March 2026, Himalaya Wellness Company launched a daily anti-anxiety ashwagandha supplement range with KSM-66 extract delivering clinically validated cortisol and anxiety reduction outcomes in a convenient daily essential format.

In February 2026, Now Health Group Inc. introduced a comprehensive anti-anxiety daily essentials kit combining standardized ashwagandha, L-theanine, and magnesium glycinate formulations with an aromatherapy roller and breathing guidance card.

In January 2026, Haleon plc expanded its consumer mental wellness portfolio with a daily calming supplement featuring clinically validated passionflower and lemon balm extract combination for anxiety and stress management.

Product Types Covered:

  • Calming Supplements
  • Stress Relief Beverages
  • Aromatherapy Products
  • Relaxation Kits
  • Wearable Stress Devices

Ingredient Types Covered:

  • Herbal Extracts
  • Adaptogens
  • Vitamins & Minerals
  • CBD-Based Ingredients
  • Amino Acids

Applications Covered:

  • Stress Reduction
  • Sleep Support
  • Mood Stabilization
  • Cognitive Relaxation
  • Emotional Wellness

Distribution Channels Covered:

  • Online Platforms
  • Pharmacies
  • Supermarkets
  • Specialty Stores
  • Wellness Clinics

End Users Covered:

  • Adults
  • Teenagers
  • Geriatric Population
  • Working Professionals
  • Students

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Anti-Anxiety Daily Essentials Market, By Product Type

  • 5.1 Calming Supplements
  • 5.2 Stress Relief Beverages
  • 5.3 Aromatherapy Products
  • 5.4 Relaxation Kits
  • 5.5 Wearable Stress Devices

6 Global Anti-Anxiety Daily Essentials Market, By Ingredient Type

  • 6.1 Herbal Extracts
  • 6.2 Adaptogens
  • 6.3 Vitamins & Minerals
  • 6.4 CBD-Based Ingredients
  • 6.5 Amino Acids

7 Global Anti-Anxiety Daily Essentials Market, By Application

  • 7.1 Stress Reduction
  • 7.2 Sleep Support
  • 7.3 Mood Stabilization
  • 7.4 Cognitive Relaxation
  • 7.5 Emotional Wellness

8 Global Anti-Anxiety Daily Essentials Market, By Distribution Channel

  • 8.1 Online Platforms
  • 8.2 Pharmacies
  • 8.3 Supermarkets
  • 8.4 Specialty Stores
  • 8.5 Wellness Clinics

9 Global Anti-Anxiety Daily Essentials Market, By End User

  • 9.1 Adults
  • 9.2 Teenagers
  • 9.3 Geriatric Population
  • 9.4 Working Professionals
  • 9.5 Students

10 Global Anti-Anxiety Daily Essentials Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 Nestle S.A.
  • 13.2 Abbott Laboratories
  • 13.3 Danone S.A.
  • 13.4 Herbalife Nutrition Ltd.
  • 13.5 Amway Corporation
  • 13.6 GSK plc
  • 13.7 Bayer AG
  • 13.8 Pfizer Inc.
  • 13.9 Unilever PLC
  • 13.10 Procter & Gamble Co.
  • 13.11 Reckitt Benckiser Group
  • 13.12 Haleon plc
  • 13.13 Blackmores Limited
  • 13.14 Nature's Bounty Co.
  • 13.15 Now Health Group Inc.
  • 13.16 Garden of Life
  • 13.17 Himalaya Wellness Company

List of Tables

  • Table 1 Global Anti-Anxiety Daily Essentials Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Anti-Anxiety Daily Essentials Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Anti-Anxiety Daily Essentials Market Outlook, By Calming Supplements (2023-2034) ($MN)
  • Table 4 Global Anti-Anxiety Daily Essentials Market Outlook, By Stress Relief Beverages (2023-2034) ($MN)
  • Table 5 Global Anti-Anxiety Daily Essentials Market Outlook, By Aromatherapy Products (2023-2034) ($MN)
  • Table 6 Global Anti-Anxiety Daily Essentials Market Outlook, By Relaxation Kits (2023-2034) ($MN)
  • Table 7 Global Anti-Anxiety Daily Essentials Market Outlook, By Wearable Stress Devices (2023-2034) ($MN)
  • Table 8 Global Anti-Anxiety Daily Essentials Market Outlook, By Ingredient Type (2023-2034) ($MN)
  • Table 9 Global Anti-Anxiety Daily Essentials Market Outlook, By Herbal Extracts (2023-2034) ($MN)
  • Table 10 Global Anti-Anxiety Daily Essentials Market Outlook, By Adaptogens (2023-2034) ($MN)
  • Table 11 Global Anti-Anxiety Daily Essentials Market Outlook, By Vitamins & Minerals (2023-2034) ($MN)
  • Table 12 Global Anti-Anxiety Daily Essentials Market Outlook, By CBD-Based Ingredients (2023-2034) ($MN)
  • Table 13 Global Anti-Anxiety Daily Essentials Market Outlook, By Amino Acids (2023-2034) ($MN)
  • Table 14 Global Anti-Anxiety Daily Essentials Market Outlook, By Application (2023-2034) ($MN)
  • Table 15 Global Anti-Anxiety Daily Essentials Market Outlook, By Stress Reduction (2023-2034) ($MN)
  • Table 16 Global Anti-Anxiety Daily Essentials Market Outlook, By Sleep Support (2023-2034) ($MN)
  • Table 17 Global Anti-Anxiety Daily Essentials Market Outlook, By Mood Stabilization (2023-2034) ($MN)
  • Table 18 Global Anti-Anxiety Daily Essentials Market Outlook, By Cognitive Relaxation (2023-2034) ($MN)
  • Table 19 Global Anti-Anxiety Daily Essentials Market Outlook, By Emotional Wellness (2023-2034) ($MN)
  • Table 20 Global Anti-Anxiety Daily Essentials Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 21 Global Anti-Anxiety Daily Essentials Market Outlook, By Online Platforms (2023-2034) ($MN)
  • Table 22 Global Anti-Anxiety Daily Essentials Market Outlook, By Pharmacies (2023-2034) ($MN)
  • Table 23 Global Anti-Anxiety Daily Essentials Market Outlook, By Supermarkets (2023-2034) ($MN)
  • Table 24 Global Anti-Anxiety Daily Essentials Market Outlook, By Specialty Stores (2023-2034) ($MN)
  • Table 25 Global Anti-Anxiety Daily Essentials Market Outlook, By Wellness Clinics (2023-2034) ($MN)
  • Table 26 Global Anti-Anxiety Daily Essentials Market Outlook, By End User (2023-2034) ($MN)
  • Table 27 Global Anti-Anxiety Daily Essentials Market Outlook, By Adults (2023-2034) ($MN)
  • Table 28 Global Anti-Anxiety Daily Essentials Market Outlook, By Teenagers (2023-2034) ($MN)
  • Table 29 Global Anti-Anxiety Daily Essentials Market Outlook, By Geriatric Population (2023-2034) ($MN)
  • Table 30 Global Anti-Anxiety Daily Essentials Market Outlook, By Working Professionals (2023-2034) ($MN)
  • Table 31 Global Anti-Anxiety Daily Essentials Market Outlook, By Students (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.